{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:55:32Z","timestamp":1788929732120,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,17]]},"DOI":"10.7759\/cureus.8669","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:06:02Z","timestamp":1592413562000},"source":"Crossref","is-referenced-by-count":4,"title":["Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide"],"prefix":"10.7759","author":[{"given":"Subash","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz  M","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Chylous ascites: diagnosis, causes and treatment","volume":"63","author":"Laterre PF","year":"2000","unstructured":"Laterre PF, Dugernier T, Reynaert MS. Chylous ascites: diagnosis, causes and treatment. Acta Gastroenterol Belg. 2000, 63:260-263.","journal-title":"Acta Gastroenterol Belg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2017.00035","article-title":"Chylous ascites: a review of pathogenesis, diagnosis and treatment","volume":"6","author":"Bhardwaj R","year":"2018","unstructured":"Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl Hepatol. 2018, 6:105-113. 10.14218\/jcth.2017.00035","journal-title":"J Clin Transl Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0566-6","article-title":"The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis","volume":"54","author":"Zhou DX","year":"2009","unstructured":"Zhou DX, Zhou HB, Wang Q, Zou SS, Wang H, Hu HP. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis. Dig Dis Sci. 2009, 54:1783-1788. 10.1007\/s10620-008-0566-6","journal-title":"Dig Dis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/240473","article-title":"Chylous ascites: evaluation and management","volume":"2014","author":"Al-Busafi SA","year":"2014","unstructured":"Al-Busafi SA, Ghali P, Desch\u00eanes M, Wong P. Chylous ascites: evaluation and management. ISRN Hepatol. 2014, 2014:240473. 10.1155\/2014\/240473","journal-title":"ISRN Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14284","article-title":"Review article: the diagnostic approach and current management of chylous ascites","volume":"46","author":"Lizaola B","year":"2017","unstructured":"Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther. 2017, 46:816-824. 10.1111\/apt.14284","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2004.06.016","article-title":"The successful treatment of chylous effusions in malignant disease with octreotide","volume":"17","author":"Mincher L","year":"2005","unstructured":"Mincher L, Evans J, Jenner MW, Varney VA. The successful treatment of chylous effusions in malignant disease with octreotide. Clin Oncol. 2005, 17:118-121. 10.1016\/j.clon.2004.06.016","journal-title":"Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.3_Suppl.S1","article-title":"Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects","volume":"35","author":"Harris AG","year":"1994","unstructured":"Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994, 35:1-4. 10.1136\/gut.35.3_Suppl.S1","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2005.05.013","article-title":"Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report","volume":"38","author":"Berzigotti A","year":"2006","unstructured":"Berzigotti A, Magalotti D, Cocci C, Angeloni L, Pironi L, Zoli M. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. Dig Liver Dis. 2006, 38:138-142. 10.1016\/j.dld.2005.05.013","journal-title":"Dig Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.3.234","article-title":"Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum","volume":"85","author":"Bhatia C","year":"2001","unstructured":"Bhatia C, Pratap U, Slavik Z. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum. Arch Dis Child. 2001, 85:234-235. 10.1136\/adc.85.3.234","journal-title":"Arch Dis Child"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2005.00427.x","article-title":"Octreotide therapy for chylous ascites in a chronic dialysis patient","volume":"10","author":"Lee PH","year":"2005","unstructured":"Lee PH, Lin CL, Lai PC, Yang CW. Octreotide therapy for chylous ascites in a chronic dialysis patient. Nephrology (Carlton). 2005, 10:344-347. 10.1111\/j.1440-1797.2005.00427.x","journal-title":"Nephrology (Carlton)"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201810001-02444","article-title":"Chylous ascites and pleural effusion treated with intravenous octreotide","volume":"113","author":"Ghimire S","year":"2018","unstructured":"Ghimire S, Shah H, Yang Tsujung, Walsh J. Chylous ascites and pleural effusion treated with intravenous octreotide. Am J Gastroenterol. 2018, 113:1361.","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34681-chylous-ascites-and-pleural-effusion-treated-with-intravenous-octreotide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:28Z","timestamp":1707506608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34681-chylous-ascites-and-pleural-effusion-treated-with-intravenous-octreotide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.8669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,17]]}}}